Contracts › 75N93023C00019
75N93023C00019: Baa Research Area 001: Development of Vaccine Candidates for Biodefense, Antimicrobial Resistant (AMR) Infections and Emerging Infectious Diseases
Awarded to Icahn School of Medicine at Mount Sinai by National Institutes of Health (NIH).
$15.9Mobligated
$22.7Mpotential value
31 May 2028current end date
See modifications, all subcontractors and funding in FedSift →
| Contract | 75N93023C00019 |
|---|---|
| Awardee | Icahn School of Medicine at Mount Sinai |
| Awarding agency | National Institutes of Health (NIH) |
| Awarding office | NATIONAL INSTITUTES OF HEALTH NIAID |
| NAICS | 541715 Research and Development in the Physical, Engineering, and Life Sciences (Except Nanotechnology and Biotechnology) |
| PSC | AN12 Health R&D Services; Health Care Services; Applied Research |
| Place of performance | NY |
| Offers received | 19 |
| Period of performance | 01 June 2023 to 31 May 2028 |
| Potential end | 31 May 2028 |
| Estimated recompete solicitation | ~Q4 2027 (estimate, ~6 months before expiry) |
Source: USASpending.gov (FPDS), public federal procurement data, as the agency reported it. Our record updated 03 October 2026. The solicitation date is an estimate from the end date, not a posted date.
Other expiring 541715 contracts · All expiring contracts · USASpending record